1.36%, in that order [95]
Role of various electrolytes during GLP-1 therapy is as follows: Sodium Function: Sodium is vital for fluid balance and nerve function

Researchers theorize this may be because: GIP activation may counterbalance some GLP-1 effects on the gut Dose escalation schedule allows more gradual adaptation Different pharmacokinetic profile may produce less pronounced peaks Serious Side Effects (Both Medications): These are rare but require immediate medical attention: Pancreatitis: Severe abdominal pain that may radiate to the back Risk: Less than 1% with both medications Usually occurs in first few months of treatment Requires immediate discontinuation if suspected Gallbladder Problems: Gallstones, cholecystitis (gallbladder inflammation) Symptoms: Right upper abdominal pain, nausea, fever More common with rapid weight loss May require surgical intervention Kidney Problems: Dehydration from vomiting/diarrhea can affect kidney function Watch for decreased urination, swelling in legs Stay well-hydrated, especially during side effect periods Thyroid Tumors (Black Box Warning): Both medications carry warnings about thyroid C-cell tumors Based on rodent studies

Other weight loss and diabetes medications, such as Ozempic (semaglutide) and Wegovy (semaglutide), also slow digestion and may cause similar gastrointestinal symptoms
Yesterday, the respected STAT News Morning Rounds newsletter even asked, What cant GLP-1 drugs do? Theyve been shown to do a lot of good